Literature DB >> 15486042

OCRE: a novel domain made of imperfect, aromatic-rich octamer repeats.

Isabelle Callebaut1, Jean-Paul Mornon.   

Abstract

SUMMARY: In this study, we describe a novel domain, OCRE, which is shared by the recently identified angiogenic factor VG5Q and a specific family of RNA-binding motif proteins. The OCRE domain is characterized by a 5-fold, imperfectly repeated octameric sequence, which includes a triplet of often-conserved aromatic amino acids predicted to form a beta-strand and in which the slightly modified fifth repeat might act as a repeat terminator. Although the function of this domain remains to be elucidated, the domain architecture of OCRE containing proteins and experimental data suggest a role in RNA metabolism and/or in signalling pathways activated by the tumor necrosis factor superfamily of cytokines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486042     DOI: 10.1093/bioinformatics/bti065

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  12 in total

1.  Nuclear Magnetic Resonance Structure of a Novel Globular Domain in RBM10 Containing OCRE, the Octamer Repeat Sequence Motif.

Authors:  Bryan T Martin; Pedro Serrano; Michael Geralt; Kurt Wüthrich
Journal:  Structure       Date:  2015-12-17       Impact factor: 5.006

Review 2.  Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis.

Authors:  A A Timur; D J Driscoll; Q Wang
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

3.  Tumor suppressor properties of the splicing regulatory factor RBM10.

Authors:  Jordi Hernández; Elias Bechara; Doerte Schlesinger; Javier Delgado; Luis Serrano; Juan Valcárcel
Journal:  RNA Biol       Date:  2016       Impact factor: 4.652

4.  The splicing machinery promotes RNA-directed DNA methylation and transcriptional silencing in Arabidopsis.

Authors:  Cui-Jun Zhang; Jin-Xing Zhou; Jun Liu; Ze-Yang Ma; Su-Wei Zhang; Kun Dou; Huan-Wei Huang; Tao Cai; Renyi Liu; Jian-Kang Zhu; Xin-Jian He
Journal:  EMBO J       Date:  2013-03-22       Impact factor: 11.598

5.  Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function.

Authors:  Chun Fan; Ping Ouyang; Ayse A Timur; Ping He; Sun-Ah You; Ying Hu; Tie Ke; David J Driscoll; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Biol Chem       Date:  2009-06-25       Impact factor: 5.157

6.  Prediction of the general transcription factors associated with RNA polymerase II in Plasmodium falciparum: conserved features and differences relative to other eukaryotes.

Authors:  Isabelle Callebaut; Karine Prat; Edwige Meurice; Jean-Paul Mornon; Stanislas Tomavo
Journal:  BMC Genomics       Date:  2005-07-23       Impact factor: 3.969

7.  Structural basis for the recognition of spliceosomal SmN/B/B' proteins by the RBM5 OCRE domain in splicing regulation.

Authors:  André Mourão; Sophie Bonnal; Komal Soni; Lisa Warner; Rémy Bordonné; Juan Valcárcel; Michael Sattler
Journal:  Elife       Date:  2016-11-29       Impact factor: 8.140

8.  Clinical diagnostic exome evaluation for an infant with a lethal disorder: genetic diagnosis of TARP syndrome and expansion of the phenotype in a patient with a newly reported RBM10 alteration.

Authors:  Zöe Powis; Alexa Hart; Sara Cherny; Igor Petrik; Erika Palmaer; Sha Tang; Carolyn Jones
Journal:  BMC Med Genet       Date:  2017-06-02       Impact factor: 2.103

9.  Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions.

Authors:  Maosheng Zhan; Yumiko Hori; Naoki Wada; Jun-Ichiro Ikeda; Yuuki Hata; Keigo Osuga; Eiichi Morii
Journal:  Acta Histochem Cytochem       Date:  2016-04-05       Impact factor: 1.938

10.  High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma.

Authors:  Jianfei Tu; Xihui Ying; Dengke Zhang; Qiaoyou Weng; Weibo Mao; Li Chen; Xulu Wu; Chaoyong Tu; Jiansong Ji; Yuan Huang
Journal:  Oncotarget       Date:  2017-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.